Cargando…

Inhaled budesonide for early treatment of COVID-19

Detalles Bibliográficos
Autores principales:	Choi, Jae Chol, Kim, Won-Young
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8115938/ https://www.ncbi.nlm.nih.gov/pubmed/33991507 http://dx.doi.org/10.1016/S2213-2600(21)00217-4

Ejemplares similares

Inhaled budesonide for early treatment of COVID-19
por: San-Juan, Rafael, et al.
Publicado: (2021)

Inhaled budesonide for early treatment of COVID-19
por: Zeitlinger, Markus, et al.
Publicado: (2021)

Inhaled budesonide for early treatment of COVID-19 – Authors' reply
por: Ramakrishnan, Sanjay, et al.
Publicado: (2021)

High-dose budesonide for early COVID-19
por: Lipworth, Brian, et al.
Publicado: (2021)

High-dose budesonide for early COVID-19
por: Berezowski, Ivan, et al.
Publicado: (2021)

High-dose budesonide for early COVID-19 – Authors' reply
por: Hobbs, F D Richard, et al.
Publicado: (2021)

Early treatment with inhaled budesonide to prevent clinical deterioration in patients with COVID-19
por: Agusti, Alvar, et al.
Publicado: (2021)

Is inhaled budesonide an effective treatment for patients with mild early symptoms of COVID-19?
por: Kareemi, Hashim, et al.
Publicado: (2021)

Inhalatives Budesonid zur Therapie bei COVID-19
por: Kluge, S., et al.
Publicado: (2021)

Budesonide–formoterol (inhalation powder) in the treatment of COPD
por: Ceylan, Erkan
Publicado: (2006)

Treatment of COVID-19 by Inhaled NO to Reduce Shunt?
por: Hedenstierna, Göran, et al.
Publicado: (2020)

Budesonide/formoterol combination for reducing cough in COVID-19 patients—A case of inflated expectations!
por: Kaur, Onkardeep, et al.
Publicado: (2023)

Efficacy of inhaled budesonide for the treatment of severe equine asthma
por: Lavoie, J. P., et al.
Publicado: (2018)

Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial
por: Ramakrishnan, Sanjay, et al.
Publicado: (2021)

Add-on inhaled budesonide in the treatment of hospitalised patients with COVID-19: a randomised clinical trial
por: Agustí, Alvar, et al.
Publicado: (2022)

Inhaled Corticosteroids and COVID-19
por: Lipworth, Brian, et al.
Publicado: (2020)

Comparison of the Efficacy of Budesonide Nebulizer Suspension and Budesonide Inhalation Suspension in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Emami Ardestani, Mohammad, et al.
Publicado: (2018)

Inhalable Nano-Dimpled Microspheres Containing Budesonide-PLGA for Improved Aerodynamic Performance
por: Han, Chang-Soo, et al.
Publicado: (2022)

Inhaled Corticosteroids and COVID-19 Risk and Mortality: A Nationwide Cohort Study
por: Choi, Jae Chol, et al.
Publicado: (2020)

Budesonide inhalation suspension versus methylprednisolone for treatment of moderate bronchial asthma attacks
por: Yanagida, Noriyuki, et al.
Publicado: (2015)

Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic review
por: Dyer, Matthew J, et al.
Publicado: (2006)

Reply to Lipworth et al.: Inhaled Corticosteroids and COVID-19
por: Maes, Tania, et al.
Publicado: (2020)

Inhaled ciclesonide for outpatients with COVID-19: A meta-analysis
por: Hsu, Chi-Kuei, et al.
Publicado: (2022)

Efficacy of budesonide/formoterol maintenance and reliever therapy compared with higher-dose budesonide as step-up from low-dose inhaled corticosteroid treatment
por: Jenkins, Christine R., et al.
Publicado: (2017)

Bronchodilatory effect of inhaled budesonide/formoterol and budesonide/salbutamol in acute asthma: a double-blind, randomized controlled trial
por: Arun, Jenish J, et al.
Publicado: (2012)

Budesonide: A promising candidate therapeutic for early COVID-19
por: Patel, Shailesh Kumar, et al.
Publicado: (2021)

Use of aerosol inhalation treatment with budesonide and terbutaline sulfate on acute pediatric asthmatic bronchitis
por: Bian, Fangfang, et al.
Publicado: (2017)

Potential for personalised application of inhaled nitric oxide in COVID-19 pneumonia
por: Garfield, Benjamin, et al.
Publicado: (2021)

Exposure-Response and Clinical Outcome Modeling of Inhaled Budesonide/Formoterol Combination in Asthma Patients
por: Back, Hyun-moon, et al.
Publicado: (2020)

Development and Evaluation of Inhalational Liposomal System of Budesonide for Better Management of Asthma
por: Parmar, J. J., et al.
Publicado: (2010)

Improved oxygenation with inhaled milrinone in mechanically ventilated patients with severe COVID-19
por: Vogel, Dominik J., et al.
Publicado: (2021)

Subcutaneous terbutaline as an alternative to metered‐dose inhalers for asthma during the COVID‐19 pandemic
por: Strauss, Ronald A.
Publicado: (2020)

Guillain-Barré syndrome after vaccination against COVID-19
por: Chun, June Young, et al.
Publicado: (2022)

The Combination of Tiotropium and Budesonide in the Treatment of Chronic Obstructive Pulmonary Disease
por: Um, Sang-Won, et al.
Publicado: (2007)

Long-term maintenance of pediatric asthma: focus on budesonide/formoterol inhalation aerosol
por: Huynh, Peter N, et al.
Publicado: (2010)

Adrenal suppression in an asthmatic presenting after change from high dose inhaled fluticasone propionate to inhaled budesonide
por: Abdurahman, Zainab B, et al.
Publicado: (2010)

Aerosol Transmission of SARS-CoV-2: Inhalation as well as Exhalation Matters for COVID-19
por: Philip, Keir E. J., et al.
Publicado: (2021)

COVID-19 and upper respiratory tract: Collecting swab specimens from patients inhaling corticosteroids
por: Siniorakis, Eftychios, et al.
Publicado: (2020)

The Imperative of Early Treatment for Children With COVID-19 Infection
por: Elenga, Narcisse
Publicado: (2020)

Inhaled nitric oxide minimally improves oxygenation in COVID-19 related acute respiratory distress syndrome
por: Longobardo, Alessia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_va77b4vkniq37o1d82pvf83gof